• Learning Objective 1: Summarize the new 2023 GOLD COPD definition, assessment, treatment recommendations.
  • Learning Objective 2: Evaluate the use of SGLT2 inhibitors in slowing progression of kidney disease and hospitalizations for patients with CKD.
  • Learning Objective 3: Evaluate the effectiveness of targeted morning discharge time for hospital throughput.
Session date: 
10/10/2023 - 3:00pm to 4:00pm CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
John Murray, MD & Tokhanh Nguyen, MD